Tower Research Capital LLC (Trc) Cti Biopharma Corp Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
SELL
$4.2 - $6.01 $116,978 - $167,390
-27,852 Reduced 78.55%
7,604 $32,000
Q4 2022

Feb 10, 2023
BUY
$4.45 - $6.17 $116,501 - $161,530
26,180 Added 282.23%
35,456 $213,000
Q3 2022

Nov 10, 2022
SELL
$5.36 - $7.43 $89,206 - $123,657
-16,643 Reduced 64.21%
9,276 $54,000
Q2 2022

Aug 15, 2022
BUY
$3.55 - $6.27 $46,600 - $82,306
13,127 Added 102.62%
25,919 $154,000
Q1 2022

May 12, 2022
SELL
$1.9 - $5.23 $20,508 - $56,452
-10,794 Reduced 45.76%
12,792 $60,000
Q4 2021

Feb 14, 2022
BUY
$1.44 - $2.86 $29,312 - $58,218
20,356 Added 630.22%
23,586 $59,000
Q3 2021

Nov 15, 2021
BUY
$2.25 - $3.18 $7,267 - $10,271
3,230 New
3,230 $10,000
Q1 2021

May 17, 2021
SELL
$2.68 - $3.8 $63,958 - $90,687
-23,865 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$2.48 - $3.8 $31,086 - $47,633
12,535 Added 110.64%
23,865 $77,000
Q3 2020

Nov 16, 2020
BUY
$1.02 - $2.15 $11,137 - $23,475
10,919 Added 2656.69%
11,330 $24,000
Q2 2020

Aug 13, 2020
BUY
$0.88 - $1.32 $361 - $542
411 New
411 $0
Q1 2020

May 15, 2020
SELL
$0.69 - $1.54 $1,762 - $3,933
-2,554 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$0.72 - $1.64 $1,838 - $4,188
2,554 New
2,554 $4,000
Q3 2019

Nov 05, 2019
SELL
$0.64 - $0.92 $11,196 - $16,095
-17,495 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$0.8 - $1.03 $11,886 - $15,303
14,858 Added 563.44%
17,495 $15,000
Q1 2019

May 14, 2019
SELL
$0.9 - $1.37 $13,317 - $20,271
-14,797 Reduced 84.87%
2,637 $3,000
Q4 2018

Feb 14, 2019
BUY
$0.73 - $2.19 $9,684 - $29,052
13,266 Added 318.28%
17,434 $13,000
Q3 2018

Nov 13, 2018
SELL
$1.72 - $5.24 $16,102 - $49,056
-9,362 Reduced 69.19%
4,168 $9,000
Q2 2018

Aug 15, 2018
BUY
$3.81 - $5.26 $29,813 - $41,159
7,825 Added 137.16%
13,530 $67,000
Q1 2018

May 15, 2018
BUY
$2.7 - $4.06 $15,403 - $23,162
5,705 New
5,705 $22,000
Q4 2017

Feb 09, 2018
SELL
$2.47 - $3.34 $10,371 - $14,024
-4,199 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$3.12 - $3.65 $13,100 - $15,326
4,199
4,199 $13,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email